Another statement from this post that is not true from the perspective of the shareholderr.
"Ethema Health has already paid off the cost of ARIA in cash and restricted $GRST stocks."
All the financing that went into the funding of ARIA has not been converted to shares and is currently eligible to convert. Ethema does not have cash other than from these notes because they loose a couple of million dollars per quarter.
"The Company required debt capital to fund the start-up of the new treatment center and now must turn its attention to managing the repayment of the debt while maintaining shareholder value. The Company expects to make significant progress on the debt in the coming months while it continues to grow the treatment center business."
The only conversions that can be attributed to the two Labrys notes for $780K to dateappears to be the July 7th conversion of $100,800. Two notes matured last week for a total of $192,500. That is a total of $871,700 in eligible conversions that have serious price protections that can convert at any time at a steep discount to market. This is not accounting for the warrants and other debt that can convert on demand. They need to get busy if that cloud of dilution hanging over this stock is to dissipate.
May 10th they signed onto financing for $550K with Labrys and that value was eligible to convert per the date of issue. According to the latest filing only $100K or 112 million shares have been issued with a conversion price of .0009 a share.
June 4th they signed onto financing for $230K with Labrys and that value was eligible to convert per the date of issue. "Conversion Rights" and adjustable "Conversion Price" language below. 10.02 Convertible Promissory Note dated June 4, 2021 (Labrys Note)
https://sec.report/Document/0001721868-21-000350/ On July 7, 2021, in terms of a conversion notice received by the company, Labrys converted the aggregate principal sum of $100,800 into 112,000,000 shares of common stock.
On August 6, 2021, the company received a cashless warrant exercise from Labrys, exercising warrants for 100,000,000 shares for net shares of 86,333,333 shares of common stock.
Two notes were issued for $192,500 combined and they mature today. With the current lowest closing of .0018 they will likely get their roughly 275 million shares at around .0007.
Market Data 
Markets 
